NASDAQ : BBNX
Beta Bionics, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 17.58 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 955.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Beta Bionics, Inc. (BBNX) reported revenue of 127.27M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 127.27M | 100.25M | 65.12M | 11.99M | 179.00K |
| Cost of Revenue | 52.65M | 44.71M | 29.24M | 5.69M | |
| Gross Profit | 74.61M | 55.54M | 35.89M | 6.31M | 179.00K |
| Selling, General & Admin | 124.49M | 92.43M | 54.95M | 24.21M | 33.49M |
| Research & Development | 42.70M | 34.79M | 26.18M | 17.94M | 31.43M |
| Operating Expenses | 167.20M | 127.22M | 81.14M | 42.16M | 64.92M |
| Operating Income | -92.58M | -71.68M | -45.25M | -35.85M | -64.74M |
| Interest Expense | -14.00K | ||||
| Interest & Investment Income | 9.47M | 10.93M | 3.91M | 1.78M | 196.00K |
| Other Non Operating Income (Expenses) | -4.00K | -12.45M | -13.41M | -10.03M | 911.00K |
| EBT Excluding Unusual Items | -83.12M | -73.20M | -54.76M | -44.10M | -63.65M |
| Other Unusual Items | -1.10M | ||||
| Pretax Income | -83.12M | -73.20M | -54.76M | -44.10M | -64.75M |
| Net Income | -83.12M | -73.20M | -54.76M | -44.10M | -64.75M |
| Net Income to Common | -83.12M | -73.20M | -54.76M | -44.10M | -64.75M |
| Shares Outstanding (Basic) | 44.98M | 40.53M | 6.37M | 5.30M | 5.00M |
| Shares Outstanding (Diluted) | 44.98M | 40.53M | 6.37M | 5.30M | 5.00M |
| EPS (Basic) | -1.85 | -1.81 | -8.60 | -8.31 | -12.96 |
| EPS (Diluted) | -1.85 | -1.81 | -8.60 | -8.31 | -12.96 |
| Free Cash Flow | -65.96M | -56.22M | -51.67M | -32.85M | -60.98M |
| Free Cash Flow Per Share | -1.47 | -1.39 | -8.12 | -6.19 | -12.20 |
| Gross Margin | 58.63% | 55.40% | 55.11% | 52.59% | 100.00% |
| Operating Margin | -72.75% | -71.50% | -69.48% | -298.88% | -36,169.83% |
| Profit Margin | -65.31% | -73.02% | -84.08% | -367.64% | -36,173.74% |
| Free Cash Flow Margin | -51.83% | -56.08% | -79.34% | -273.84% | -34,067.04% |
| EBITDA | -89.86M | -70.11M | -44.10M | -34.62M | -63.40M |
| EBITDA Margin | -70.61% | -69.93% | -67.72% | -288.65% | |
| D&A For EBITDA | 2.72M | 1.57M | 1.15M | 1.23M | 1.34M |
| EBIT | -92.58M | -71.68M | -45.25M | -35.85M | -64.74M |
| EBIT Margin | -72.75% | -71.50% | -69.48% | -298.87% | |
| Revenue as Reported | 179.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 81.55M | 31.58M | 30.43M | 26.57M | 27.68M |
| Short-Term Investments | 158.65M | 187.55M | 73.14M | 70.18M | |
| Cash & Short-Term Investments | 240.20M | 219.12M | 103.58M | 96.75M | 27.68M |
| Accounts Receivable | 20.67M | 17.12M | 12.00M | 4.45M | |
| Other Receivables | 3.08M | 2.78M | 1.05M | ||
| Receivables | 23.75M | 19.89M | 13.05M | 4.45M | |
| Inventory | 22.97M | 21.72M | 13.32M | 1.25M | |
| Prepaid Expenses | 5.92M | 7.06M | 2.98M | 908.00K | 542.00K |
| Restricted Cash | 100.00K | 100.00K | |||
| Other Current Assets | 275.00K | 250.00K | |||
| Total Current Assets | 292.95M | 267.90M | 132.92M | 103.62M | 28.47M |
| Property, Plant & Equipment | 17.16M | 15.23M | 11.42M | 6.20M | 6.87M |
| Long-Term Investments | 133.44M | 45.43M | |||
| Long-Term Deferred Charges | 5.05M | ||||
| Other Long-Term Assets | 212.00K | 180.00K | 250.00K | 221.00K | 193.00K |
| Total Assets | 443.76M | 328.74M | 149.65M | 110.04M | 35.53M |
| Accounts Payable | 4.68M | 5.00M | 2.85M | 1.17M | 430.00K |
| Accrued Expenses | 18.58M | 17.34M | 13.33M | 7.07M | 6.14M |
| Current Portion of Leases | 1.45M | 1.94M | 1.53M | 1.22M | 976.00K |
| Current Unearned Revenue | 2.05M | 1.56M | 939.00K | 87.00K | |
| Other Current Liabilities | 6.08M | 5.10M | 2.50M | 1.05M | 1.32M |
| Total Current Liabilities | 32.84M | 30.92M | 21.15M | 10.61M | 8.87M |
| Long-Term Leases | 4.65M | 5.37M | 5.73M | 3.00M | 3.16M |
| Long-Term Unearned Revenue | 3.48M | 3.30M | 1.86M | 255.00K | |
| Other Long-Term Liabilities | 1.41M | 1.55M | 44.90M | 37.57M | 10.50M |
| Total Liabilities | 42.38M | 41.13M | 73.63M | 51.43M | 22.53M |
| Common Stock | 5.00K | 4.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 841.84M | 657.14M | 51.31M | 26.42M | 15.53M |
| Retained Earnings | -439.59M | -369.94M | -296.74M | -229.66M | -185.56M |
| Comprehensive Income & Other | -877.00K | 403.00K | 65.00K | 137.00K | |
| Total Common Equity | 401.38M | 287.61M | -245.36M | -203.10M | -170.03M |
| Shareholders' Equity | 401.38M | 287.61M | 76.01M | 58.61M | 13.00M |
| Total Liabilities & Equity | 443.76M | 328.74M | 149.65M | 110.04M | 35.53M |
| Total Debt | 6.10M | 7.30M | 7.25M | 4.22M | 4.13M |
| Net Cash (Debt) | 234.10M | 211.82M | 96.32M | 92.52M | 23.54M |
| Net Cash Per Share | 5.20 | 5.23 | 15.13 | 17.44 | 4.71 |
| Filing Date Shares Outstanding | 54.37M | 44.38M | 43.35M | 5.03M | 5.00M |
| Total Common Shares Outstanding | 54.36M | 44.36M | 6.67M | 5.03M | 5.00M |
| Working Capital | 260.11M | 236.98M | 111.78M | 93.02M | 19.59M |
| Book Value Per Share | 7.38 | 6.48 | -36.80 | -40.39 | -34.02 |
| Tangible Book Value | 401.38M | 287.61M | -245.36M | -203.10M | -170.03M |
| Tangible Book Value Per Share | 7.38 | 6.48 | -36.80 | -40.39 | -34.02 |
| Machinery | 14.88M | 10.19M | 7.48M | 5.78M | 5.56M |
| Construction In Progress | 1.96M | 3.34M | 1.74M | 167.00K | 182.00K |
| Leasehold Improvements | 2.86M | 830.00K | 810.00K | 951.00K | 951.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -83.12M | -73.20M | -54.76M | -44.10M | -64.75M |
| Depreciation & Amortization | 4.35M | 2.88M | 2.28M | 2.09M | 2.09M |
| Other Amortization | 14.00K | ||||
| Loss (Gain) From Sale of Assets | 117.00K | 31.00K | 23.00K | 11.00K | 43.00K |
| Loss (Gain) From Sale of Investments | 266.00K | -1.99M | -2.90M | -747.00K | |
| Stock-Based Compensation | 23.44M | 16.38M | 6.38M | 5.66M | 6.10M |
| Provision & Write-off of Bad Debts | 68.00K | 40.00K | 70.00K | 46.00K | |
| Other Operating Activities | 287.00K | 13.93M | 12.78M | 9.90M | -911.00K |
| Change in Accounts Receivable | -9.20M | -5.16M | -7.62M | -4.49M | |
| Change in Inventory | -2.88M | -9.88M | -11.44M | -1.19M | |
| Change in Accounts Payable | -296.00K | 2.10M | 1.51M | 716.00K | -77.00K |
| Change in Unearned Revenue | 1.20M | 2.06M | 2.46M | 342.00K | -179.00K |
| Change in Other Net Operating Assets | 6.40M | 1.90M | 2.94M | -682.00K | -2.53M |
| Operating Cash Flow | -59.37M | -50.92M | -48.27M | -32.45M | -60.21M |
| Capital Expenditures | -6.59M | -5.30M | -3.40M | -402.00K | -772.00K |
| Sale of Property, Plant & Equipment | 50.00K | 4.00K | 3.00K | ||
| Investment in Securities | -58.06M | -157.51M | -131.00K | -69.30M | |
| Investing Cash Flow | -64.65M | -162.81M | -3.48M | -69.69M | -769.00K |
| Issuance of Common Stock | 167.08M | 214.87M | 102.00K | 29.00K | 389.00K |
| Other Financing Activities | -4.15M | 11.41M | |||
| Financing Cash Flow | 167.08M | 214.87M | 55.62M | 101.03M | 56.78M |
| Net Cash Flow | 43.07M | 1.14M | 3.87M | -1.11M | -4.20M |
| Free Cash Flow | -65.96M | -56.22M | -51.67M | -32.85M | -60.98M |
| Free Cash Flow Margin | -51.83% | -56.08% | -79.34% | -273.84% | -34,067.04% |
| Free Cash Flow Per Share | -1.47 | -1.39 | -8.12 | -6.19 | -12.20 |
| Levered Free Cash Flow | -40.10M | -40.90M | -35.24M | -19.66M | |
| Unlevered Free Cash Flow | -40.10M | -40.90M | -35.24M | -19.66M | |
| Change in Working Capital | -4.78M | -8.99M | -12.15M | -5.30M | -2.79M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 900.32M | 1.34B | |||
| Enterprise Value | 666.22M | 1.12B | |||
| Last Close Price | 16.75 | 30.47 | |||
| PS Ratio | 7.16 | 13.38 | |||
| PB Ratio | 2.27 | 4.66 | |||
| P/TBV Ratio | 2.27 | 4.66 | |||
| EV/Sales Ratio | 5.32 | 11.18 | |||
| Debt / Equity Ratio | 0.01 | 0.03 | 0.10 | 0.07 | 0.32 |
| Net Debt / Equity Ratio | -0.58 | -0.74 | -1.27 | -1.58 | -1.81 |
| Net Debt / EBITDA Ratio | 2.60 | 3.02 | 2.18 | 2.67 | 0.37 |
| Net Debt / FCF Ratio | 3.55 | 3.77 | 1.86 | 2.82 | 0.39 |
| Asset Turnover | 0.33 | 0.42 | 0.50 | 0.17 | |
| Inventory Turnover | 2.43 | 2.55 | 4.01 | ||
| Quick Ratio | 8.04 | 7.73 | 5.51 | 9.54 | 3.12 |
| Current Ratio | 8.92 | 8.66 | 6.29 | 9.77 | 3.21 |
| Return on Equity (ROE) | -23.88% | -40.26% | -81.35% | -123.17% | |
| Return on Assets (ROA) | -14.96% | -18.73% | -21.78% | -30.79% | |
| Return on Capital Employed (ROCE) | -22.50% | -24.10% | -35.20% | -36.10% | -242.90% |
| Earnings Yield | -11.16% | -5.46% | |||
| FCF Yield | -7.24% | -4.19% | |||
| Buyback Yield / Dilution | -44.45% | -536.74% | -20.01% | -6.13% |